XVII. Radiotherapy in early stage Hodgkin lymphoma

Hematological Oncology

Volumn 31, Issue SUPPL 2, 2013, Pages 92-95

  Illidge, Tim ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chemotherapy; Clinical trials; FDG PET; Hodgkin Lymphoma; Radiotherapy

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; PREDNISOLONE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; HODGKIN DISEASE; HUMAN; INVOLVED FIELD RADIOTHERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE;

HODGKIN DISEASE; HUMANS; NEOPLASM STAGING;

EID: 84879388854     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.2075     Document Type: Article

References (16)

1. Kaplan HS, Rosenberg SA. Extended-field radical radiotherapy in advanced Hodgkin's disease: short-term results of 2 randomized clinical trials. Cancer Res 1966 Jun; 26(6): 1268-762.
2. Specht L, Gray RG, Clarke MJ, Peto R. The influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3888 patients. J Clin Oncol 1998; 16: 830-43.
3. Engert A, Plutschow A, Eich HT, et al. Reduced treatment intensity in patients with early-stage Hodgkin lymphoma. N Engl J Med 2010; 363: 640-652.
4. Eich HT, Diehl V, Gorgen H, et al. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. J Clin Oncol 2010; 28: 4.
5. Ng A, Travis L. In Acute and long-term complications of radiotherapy for Hodgkin Lymphoma. Specht L, Yahalom J (eds). Radiotherapy for Hodgkin Lymphoma: New York, Springer, 2011; 183-196. Boivin JF, O'Brien K, Solid cancer risk after treatment of Hodgkin's disease. Cancer 2541-2546; 61: 1988 199-4206.
6. Meyer RM, Gospodarowicz MK, Connors JM, et al. ABVD versus radiation based therapy in limited stage Hodgkin lymphoma. N Engl J Med 2012; 366: 399-408.
7. Hodgson DC, Koh ES, Tran TH, et al. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma. Cancer 2007; 110: 2576-2586.9.
8. Böll B, Görgen H, Fuchs M, et al. ABVD in older patients with early-stage hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 Trials. J Clin Oncol 2013; Mar 18. [Epub ahead of print]
9. Lund MB, Kongerud J, Nome O, et al. Lung function impairment in long-term survivors of Hodgkin's disease. Ann Oncol 1995 May; 6(5): 495-501.
10. Von Hoff DD, Layard MW, Basa P, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979; 9: 710-7.
11. Swerdlow AJ, Higgins CD, Smith P, et al. Myocardial Risk after treatment for Hodgkin Disease: a collaborative British cohort study. J Natl Cancer Inst 2007; 99: 206-214.
12. Herbst C, Rehan FA, Skoetz N, et al. Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma. Cochrane Database Syst Rev. 2011; Feb 16(2).
13. Radford J, Barrington S, Counsell N, et al. Involved field radiotherapy versus no further treatment in patients with clinical stages I A and II A Hodgkin Lymphoma and a 'Negative' PET scan after 3 cycles ABVD. Results of the UK NCRI RAPID Trial Blood 2012 547a.
14. André M, Reman O, Federico M, et al. Interim analysis of the randomized Eortc/Lysa/Fil Intergroup H10 trial on early PET-scan driven treatment adaptation in stage I/II Hodgkin Lymphoma Blood 2012 549a
15. Radford J. Treatment for early-stage hodgkin lymphoma: has radiotherapy had its day? J Clin Oncol. 2012 Nov 1; 30(31): 3783-5.
16. Engert A. Radiotherapy in Early-stage Hodgkin Lymphoma June 15, 2012, Vol 3, Issue 9 ASCO post.